EDWARD GRAVISS to Antiretroviral Therapy, Highly Active
This is a "connection" page, showing publications EDWARD GRAVISS has written about Antiretroviral Therapy, Highly Active.
Connection Strength
0.323
-
Normalization of FoxP3(+) regulatory T cells in response to effective antiretroviral therapy. J Infect Dis. 2011 Feb 15; 203(4):496-9.
Score: 0.081
-
Community outreach with weekly delivery of anti-retroviral drugs compared to cognitive-behavioural health care team-based approach to improve adherence among indigent women newly starting HAART. AIDS Care. 2006 May; 18(4):332-8.
Score: 0.059
-
Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 2005 Mar 04; 19(4):399-406.
Score: 0.054
-
Determinants of sustained virological suppression in indigent, HIV-infected patients: is single protease inhibitor-based antiretroviral therapy truly highly active? HIV Clin Trials. 2004 May-Jun; 5(3):117-24.
Score: 0.051
-
Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic. J Acquir Immune Defic Syndr. 2003 Apr 01; 32(4):399-405.
Score: 0.047
-
One year survival of HIV-infected veterans with CD4 < 100 cells/mm3: data from a veteran cohort. AIDS Care. 2010 Jul; 22(7):886-94.
Score: 0.020
-
Do sex and race/ethnicity influence CD4 cell response in patients who achieve virologic suppression during antiretroviral therapy? Clin Infect Dis. 2003 Aug 01; 37(3):433-7.
Score: 0.012